EP3519419
BETA-LAKTAMSE HEMLAR
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.9.2017EP published:
27.5.2020EP application number:
17791737.4
EP translation filed:
22.6.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
27.9.2037Expiry date:
27.9.2022
Title:
BETA-LACTAMASE INHIBITORS
Timeline
Today
28.9.2017EP application
27.5.2020EP Publication
22.6.2020Translation submitted
15.8.2020Registration published
27.9.2022Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CASAREZ, AnthonyAddress:
Emeryville, California 94608, US
Name:
FUREGATI, MarkusAddress:
4002 Basel, CH
Name:
KOCH, GuidoAddress:
4002 Basel, CH
Name:
LIN, XiaodongAddress:
Emeryville, California 94608, US
Name:
OSSOLA, FlavioAddress:
4002 Basel, CH
Name:
RECK, FolkertAddress:
Emeryville, California 94608, US
Name:
SIMMONS, Robert LowellAddress:
Emeryville, California 94608, US
Name:
ZHU, QingmingAddress:
Emeryville, California 94608, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201662401022 PDate:
28.9.2016Country:
US
Classification
Categories:
C07D 471/18, A61K 31/496, A61K 45/06, A61K 31/5025, A61K 31/551, A61K 31/546, A61K 31/407, A61P 31/04, A61K 31/427, A61K 31/431, A61K 31/4545
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 18.9.2020
Expires: 27.9.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 5
Paid: 10.9.2021
Expires: 27.9.2022
Payer: G.H. Sigurgeirsson ehf.